Sight Diagnostics products

The CBC analyzer that accelerates time to diagnosis and treatment. Sight OLO provides 5-part CBC results with 19 parameters and sophisticated flagging capabilities. It is the first CBC analyzer that is FDA 510(k) cleared for blood taken directly from either a finger prick or a venous sample.

Sight’s digital pathology and AI-based hematology platform achieves lab-grade diagnostic accuracy using only two drops of blood. No external reagent management, no maintenance, and no manual calibration required by manufacturer.